JPS5926640B2 - 生殖抑制活性を有するエチステロン誘導体の製造方法 - Google Patents

生殖抑制活性を有するエチステロン誘導体の製造方法

Info

Publication number
JPS5926640B2
JPS5926640B2 JP49023481A JP2348174A JPS5926640B2 JP S5926640 B2 JPS5926640 B2 JP S5926640B2 JP 49023481 A JP49023481 A JP 49023481A JP 2348174 A JP2348174 A JP 2348174A JP S5926640 B2 JPS5926640 B2 JP S5926640B2
Authority
JP
Japan
Prior art keywords
hydrogen
cycloalkyl
compound
lower alkyl
ethynyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP49023481A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5029550A (cg-RX-API-DMAC7.html
Inventor
エイ セツテパニ ジヨセフ
エル マクカイア− ジヨン
ヒ− シユロフ ア−ウイン
ハン ドウオン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ortho Pharmaceutical Corp
Original Assignee
Ortho Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Pharmaceutical Corp filed Critical Ortho Pharmaceutical Corp
Publication of JPS5029550A publication Critical patent/JPS5029550A/ja
Publication of JPS5926640B2 publication Critical patent/JPS5926640B2/ja
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/004—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0048—Alkynyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C07J41/0016—Oximes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP49023481A 1973-03-01 1974-03-01 生殖抑制活性を有するエチステロン誘導体の製造方法 Expired JPS5926640B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33723673A 1973-03-01 1973-03-01
US337236 1973-03-01

Publications (2)

Publication Number Publication Date
JPS5029550A JPS5029550A (cg-RX-API-DMAC7.html) 1975-03-25
JPS5926640B2 true JPS5926640B2 (ja) 1984-06-29

Family

ID=23319690

Family Applications (1)

Application Number Title Priority Date Filing Date
JP49023481A Expired JPS5926640B2 (ja) 1973-03-01 1974-03-01 生殖抑制活性を有するエチステロン誘導体の製造方法

Country Status (7)

Country Link
JP (1) JPS5926640B2 (cg-RX-API-DMAC7.html)
AT (1) AT343292B (cg-RX-API-DMAC7.html)
CA (1) CA1034942A (cg-RX-API-DMAC7.html)
CH (1) CH606108A5 (cg-RX-API-DMAC7.html)
DE (1) DE2409648A1 (cg-RX-API-DMAC7.html)
FR (1) FR2219783B1 (cg-RX-API-DMAC7.html)
GB (1) GB1452179A (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0568898U (ja) * 1992-02-19 1993-09-17 株式会社明和スクリーン プルトップ部オープナ

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2664895B1 (fr) * 1990-07-20 1992-10-30 Theramex Laboratoire Nouveaux derives de la 6-methyl 19-nor progesterone, substitues en 3 et leur procede d'obtention.
AU3257993A (en) * 1991-12-22 1993-07-28 Schering Aktiengesellschaft 3-methylsulphonylhydrazono and 3-oxyimino steroids, a method of preparing them, pharmaceutical preparations containing them and their use in the preparation of drugs
HUP0301981A2 (hu) * 2003-06-30 2005-04-28 Richter Gedeon Vegyészeti Gyár Rt. Tiszta d-(17alfa)-13-etil-17-hidroxi-18,19-dinor-pregn-4-én-20-in-3-on-3E- és 3Z-oxim izomerek, valamint eljárás az izomer keverékek és a tiszta izomerek előállítására
US7816546B2 (en) 2003-06-30 2010-10-19 Richter Gedeon Vegyeszeti Gyar Rt. Process for the synthesis of high purity d-(17α)-13-ethyl-17-hydroxy-18,19-dinorpregn-4-ene-20-yn-3-one-oxime

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3299107A (en) * 1965-02-12 1967-01-17 Searle & Co 17-(unsaturated hydrocarbon-substituted)-3-hydroxyimino-5alpha-androstan-17beta-ols,alkyl and acyl derivatives thereof
US3686237A (en) * 1969-12-04 1972-08-22 Ortho Pharma Corp O-(nitroaryl)oximes of 3-keto steroids

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0568898U (ja) * 1992-02-19 1993-09-17 株式会社明和スクリーン プルトップ部オープナ

Also Published As

Publication number Publication date
FR2219783A1 (cg-RX-API-DMAC7.html) 1974-09-27
AT343292B (de) 1978-05-26
CA1034942A (en) 1978-07-18
FR2219783B1 (cg-RX-API-DMAC7.html) 1977-06-03
JPS5029550A (cg-RX-API-DMAC7.html) 1975-03-25
CH606108A5 (cg-RX-API-DMAC7.html) 1978-10-13
DE2409648A1 (de) 1974-09-12
GB1452179A (en) 1976-10-13
ATA165374A (de) 1977-09-15

Similar Documents

Publication Publication Date Title
CA1303025C (fr) Derives 17beta a-oh 19-nor steroides substitues en 17alpha, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant
EP0077040A1 (en) 3-Oxaestra-17-acetonitrile and unsaturated analogs, a process for their preparation and pharmaceutical compositions containing said compounds
US4027019A (en) 3-Oximes of D-17α-ethynyl-19-nortestosterone esters and method
SU1087525A1 (ru) 14 @ ,15 @ - Или 14 @ ,15 @ -метиленпроизводные эстранового р да,обладающие интерцептивным действием
JPS5926640B2 (ja) 生殖抑制活性を有するエチステロン誘導体の製造方法
US4259325A (en) 1,3-Dibenzoic acid esters of 17α-ethynyl-7α-methyl-1,3,5(10)-estratriene-1,3,17β-triol
SU1508963A3 (ru) Способ получени 11 @ -замещенных стероидов или их фармацевтически или ветеринарно приемлемых солей
EP0318490A1 (de) 14,17-g(b)-ETHANO-14-g(b)-ESTRATRIENE, VERFAHREN ZU DEREN HERSTELLUNG UND DIESE ENTHALTENDE PHARMAZEUTISCHE PRÄPARATE.
EP0443957B1 (fr) Nouveaux produits stéroides comportant un radical spiro en position 17, leur procédé de préparation et les intermédiaires de ce procédé, leur application à titre de médicaments et les compositions pharmaceutiques les renfermant
JPH0155280B2 (cg-RX-API-DMAC7.html)
US4055562A (en) Process for preparing pregn-20-yne compounds and novel product produced thereby
US4567000A (en) 11-Difluoromethylene steroids
US3480621A (en) Steroid ketal
IL28867A (en) 1-adamantyl and 1-adamantylmethyl carbonates of testosterone and derivatives thereof
US5866559A (en) 17α-cyanomethylestra-4,9-dien derivatives and pharmaceutical compositions containing same
PT1219632E (pt) Esteróides, sua preparação, suas composições farmacológicas e uso dos composto
US4073899A (en) Method of terminating pregnancy
JPS6249280B2 (cg-RX-API-DMAC7.html)
US3983112A (en) 17β-Ethynyl-3,17α-estradiol and derivatives thereof
US2636043A (en) Method of preparing 16-ketosteroids
US3674817A (en) Nitro-steroids and process for their preparation
EP1240179B1 (en) 3-methylene steroid derivatives for the treatment of autoimmune diseases
US3379743A (en) 17-enol esters of 3-oxy-17-hydroxy-polyunsaturated steroids and preparation thereof
US3682898A (en) 17-oxygenated 7alpha-methyl-2,3-epithio-5alpha-androstanes
US3976684A (en) 1-Succinoyl-2,4-disubstituted-4b,5,6,7,8,8a,9,10-octahydro-9-oxo-phenanthrenes and compositions and methods for treating lipodemia